A must have resource for clinicians and investigators interested in pulmonary embolism and deep venous thrombosis _ Highly illustrated with numerous tables and graphs alongside clear concise text _ Includes chapters addressing pulmonary embolism (PE) and deep venous thrombosis (DVT) in relation to diseases and disorders such as; chronic heart failure, cancer, diabetes, stroke, chronic obstructive pulmonary disease (COPD) and many more _ Discusses the role the different tools offered in imaging for PE, including echocardiography, multidetector computed tomography (CT), single photon emission…mehr
A must have resource for clinicians and investigators interested in pulmonary embolism and deep venous thrombosis _ Highly illustrated with numerous tables and graphs alongside clear concise text _ Includes chapters addressing pulmonary embolism (PE) and deep venous thrombosis (DVT) in relation to diseases and disorders such as; chronic heart failure, cancer, diabetes, stroke, chronic obstructive pulmonary disease (COPD) and many more _ Discusses the role the different tools offered in imaging for PE, including echocardiography, multidetector computed tomography (CT), single photon emission computed tomography (SPECT), ventilation-perfusion (V-Q) imaging, dual energy CT, and magnetic resonance angiography _ Contains 29 new chapters and includes new content on epidemiology of deep venous thrombosis; use of the new anticoagulants (dabigatran, rivaroxaban, and apixaban) for DVT and PE; indications and results with thrombolytic therapy and with vena cava filters; and information and indications for invasive mechanical thrombectomy and thrombolysis _ Written by an internationally recognized and respected expert in the field
Paul D. Stein MD, Professor of Osteopathic Medical Specialties, College of Osteopathic Medicine, Michigan State University, East Lansing, Michigan, USA. Dr. Stein's major research in recent years has been in the field of venous thromboembolism. Dr. Stein initiated the PIOPED II and PIOPED III national collaborative studies and was national principal investigator and chairperson of the steering committees. He has written over 240 articles on venous thromboembolism from among over 560 peer reviewed articles. Dr Stein is a past president of the Laennec Society and of the American College of Chest Physicians. He is Fellow of the American College of Physicians and the American College of Cardiology and a Master Fellow of the American College of Chest Physicians. He is also a Fellow of the American Society of Mechanical Engineers. Fellowship is reserved for those who have made a significant contribution to the field of mechanical engineering. He received the Lifetime Achievement Award from the American Heart Association Midwest Affiliate, the Laureate Award of the American College of Physicians, Michigan Chapter, the Daniel Drake Award from the University of Cincinnati College of Medicine, and the Research Excellence Award from the Michigan State University College of Osteopathic Medicine. Dr. Stein also wrote a book, A Physical and Physiological Basis for the Interpretation of Cardiac Auscultation: Evaluations Based Primarily on Second Sound and Ejection Murmurs.
Inhaltsangabe
Prologue xi
Preface to the Third Edition xiii
Introduction 1
Part I Prevalence, risks, and prognosis of pulmonary embolism and deep venous thrombosis
1 Pulmonary embolism and deep venous thrombosis at autopsy 5
2 Incidence of pulmonary embolism and deep venous thrombosis in hospitalized patients and in emergency departments 18
3 Case fatality rate and population mortality rate from pulmonary embolism and deep venous thrombosis 24
4 Prognosis inacutepulmonary embolism based on right ventricular enlargement and biochemical markers in stable patients 31
5 Prognosis inacutepulmonary embolism based on scoring systems 43
6 Pulmonaryembolismfollowingdeep venous thrombosis and outcome with untreated pulmonary embolism 49
7 Resolutionofpulmonaryembolism 54
8 Upper extremity deep venous thrombosis 61
9 Thromboembolic disease involving the superior vena cava and brachiocephalic veins 66
10 Venous thromboembolic disease in the four seasons 69
11 Regional differences in the United States of rates of diagnosis of pulmonary embolism and deep venous thrombosis and mortality from pulmonary embolism 73
12 Venous thromboembolism according to age and in the elderly 78
13 Pulmonary thromboembolism in infants and children 95
14 Venous thromboembolism in men and women 99
15 Pulmonary embolism and deep venous thrombosis in blacks and whites 103
16 Pulmonary thromboembolism in Asians/Pacific Islanders 108
17 Pulmonary thromboembolism in American Indians and Alaskan Natives 116
18 Venous thromboembolism in patients with cancer 118
19 Venous thromboembolism in patients with heart failure 128
20 Obesity as a risk factor in venous thromboembolism 133
21 Hypertension, smoking, and cholesterol 139
22 Overlap of venous and arterial thrombosis risk factors 141
23 Venous thromboembolism in patients with ischemic and hemorrhagic stroke 143
24 Paradoxical embolism 146
25 Pulmonary embolism and deep venous thrombosis in hospitalized adults with chronic obstructive pulmonary disease 149
26 Pulmonary embolism and deep venous thrombosis in hospitalized patients with asthma 156
27 Deep venous thrombosis and pulmonary embolism in hospitalized patients with sickle cell disease 158
28 Diabetesmellitus and risk of venous thromboembolism 162
29 Risk of venous thromboembolism with rheumatoid arthritis 164
30 Venous thromboembolism with inflammatory bowel disease 166
31 Venous thromboembolism with chronic liver disease 168
32 Nephrotic syndrome 171
33 Human immunodeficiency virus infection 173
34 Venous thromboembolism in pregnancy 176
35 Amniotic fluid embolism 182
36 Air travel as a risk for pulmonary embolism and deep venous thrombosis 184
37 Estrogen-containing oral contraceptives and venous thromboembolism 187
38 Estrogen and testosterone in men 192
39 Tamoxifen 194
40 Venous thromboembolism following bariatric surgery 198
41 Hypercoagulable syndrome 204
Part II Diagnosis of deep venous thrombosis
42 Deep venous thrombosis of the lower extremities: clinical evaluation 215
43 Clinical scoring system for assessment of deep venous thrombosis 220
44 Clinical probability score plus single negative ultrasound for exclusion of deep venous thrombosis 223
45 D-dimer for the exclusion of acute deep venous thrombosis 225
46 D-dimer combined with clinical probability assessment for exclusion of acute deep venous thrombosis 234
Part I Prevalence, risks, and prognosis of pulmonary embolism and deep venous thrombosis
1 Pulmonary embolism and deep venous thrombosis at autopsy 5
2 Incidence of pulmonary embolism and deep venous thrombosis in hospitalized patients and in emergency departments 18
3 Case fatality rate and population mortality rate from pulmonary embolism and deep venous thrombosis 24
4 Prognosis inacutepulmonary embolism based on right ventricular enlargement and biochemical markers in stable patients 31
5 Prognosis inacutepulmonary embolism based on scoring systems 43
6 Pulmonaryembolismfollowingdeep venous thrombosis and outcome with untreated pulmonary embolism 49
7 Resolutionofpulmonaryembolism 54
8 Upper extremity deep venous thrombosis 61
9 Thromboembolic disease involving the superior vena cava and brachiocephalic veins 66
10 Venous thromboembolic disease in the four seasons 69
11 Regional differences in the United States of rates of diagnosis of pulmonary embolism and deep venous thrombosis and mortality from pulmonary embolism 73
12 Venous thromboembolism according to age and in the elderly 78
13 Pulmonary thromboembolism in infants and children 95
14 Venous thromboembolism in men and women 99
15 Pulmonary embolism and deep venous thrombosis in blacks and whites 103
16 Pulmonary thromboembolism in Asians/Pacific Islanders 108
17 Pulmonary thromboembolism in American Indians and Alaskan Natives 116
18 Venous thromboembolism in patients with cancer 118
19 Venous thromboembolism in patients with heart failure 128
20 Obesity as a risk factor in venous thromboembolism 133
21 Hypertension, smoking, and cholesterol 139
22 Overlap of venous and arterial thrombosis risk factors 141
23 Venous thromboembolism in patients with ischemic and hemorrhagic stroke 143
24 Paradoxical embolism 146
25 Pulmonary embolism and deep venous thrombosis in hospitalized adults with chronic obstructive pulmonary disease 149
26 Pulmonary embolism and deep venous thrombosis in hospitalized patients with asthma 156
27 Deep venous thrombosis and pulmonary embolism in hospitalized patients with sickle cell disease 158
28 Diabetesmellitus and risk of venous thromboembolism 162
29 Risk of venous thromboembolism with rheumatoid arthritis 164
30 Venous thromboembolism with inflammatory bowel disease 166
31 Venous thromboembolism with chronic liver disease 168
32 Nephrotic syndrome 171
33 Human immunodeficiency virus infection 173
34 Venous thromboembolism in pregnancy 176
35 Amniotic fluid embolism 182
36 Air travel as a risk for pulmonary embolism and deep venous thrombosis 184
37 Estrogen-containing oral contraceptives and venous thromboembolism 187
38 Estrogen and testosterone in men 192
39 Tamoxifen 194
40 Venous thromboembolism following bariatric surgery 198
41 Hypercoagulable syndrome 204
Part II Diagnosis of deep venous thrombosis
42 Deep venous thrombosis of the lower extremities: clinical evaluation 215
43 Clinical scoring system for assessment of deep venous thrombosis 220
44 Clinical probability score plus single negative ultrasound for exclusion of deep venous thrombosis 223
45 D-dimer for the exclusion of acute deep venous thrombosis 225
46 D-dimer combined with clinical probability assessment for exclusion of acute deep venous thrombosis 234
47
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Shop der buecher.de GmbH & Co. KG Bürgermeister-Wegele-Str. 12, 86167 Augsburg Amtsgericht Augsburg HRA 13309
